Clinical Trials

Colorado Springs Neurological Associates is one of the largest and longest-standing neuroscience medical practices in southern Colorado.  Our aim is to deliver the highest standard of neurological care – the same level of care we would want for ourselves or our loved ones.  The Center has a dedicated clinical research institute with experienced principal investigators and a full-time research staff.  Collectively, our investigators have vast experience conducting phase II through phase IV clinical trials in a broad range of neurologic diseases affecting adults and children.


 

Adult Migraine

  • Atogepant for episodic migraine

Pediatric Migraine

  • Erenumab (Aimovig) for episodic and chronic migraine, ages 6-18
  • Observational study of pediatric migraine, ages 4-17, partnered with Duke University

Multiple Sclerosis

  • ADS-5102 (extended-release Amantadine) for Multiple Sclerosis patients with walking impairment
  • Observational trial for Multiple Sclerosis patients taking Tecfidera
  • Observational trial for Multiple Sclerosis patients taking Gilenya
  • Observational registry for patients with MS relapse taking Acthar gel
  • Observational trial for Multiple Sclerosis patients taking cladribine
  • Observational trial for Multiple Sclerosis patients taking siponimod
  • Phase 3 trial to assess the safety and efficacy of evobrutinib in Multiple Sclerosis

Neurogenic Orthostatic Hypotension

  • Long-term outcomes of droxidopa (Northera) in patients with orthostatic hypotension
  • Phase 3 trial to assess the safety and efficacy of TD-9855 in neurogenic orthostatic hypotension

Epilepsy

  • Phase 3 trial to assess the safety and efficacy of lacosamide for primary generalized epilepsy
  • Phase 3 trial to assess the safety and efficacy of cenobamate for adjunctive treatment of primary generalized epilepsy

Myasthenia Gravis

  • Phase 3 trial to assess the safety and efficacy of ravulizumab in patients with Myasthenia Gravis

 

 

Please contact research coordinator, Jodi for additional information:

Jodi Ventimiglia 719-389-1126  jventimiglia@csneuro.com

Research Staff